Advertisement
U.S. Markets closed
S&P Futures
5,888.00 -8.25 (-0.14%) Dow Futures
43,135.00 -42.00 (-0.10%) Nasdaq Futures
20,475.75 -43.75 (-0.21%) Russell 2000 Futures
2,250.50 -5.00 (-0.22%) Crude Oil
70.27 -0.29 (-0.41%) Gold
2,743.50 +4.60 (+0.17%)
Therapeutic Solutions International, Inc. (TSOI)
OTC Markets OTCPK - OTC Markets OTCPK Delayed Price. Currency in USD
Follow
At close: 03:10PM EDT
Currency in USD
Valuation Measures4
| Market Cap (intraday) | 3.42M |
| Enterprise Value | 4.37M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 29.63 |
| Price/Book (mrq) | 2.60 |
| Enterprise Value/Revenue | 47.84 |
| Enterprise Value/EBITDA | -2.00 |
Trading Information
Stock Price History
| Beta (5Y Monthly) | 1.64 |
| 52-Week Change 3 | N/A |
| S&P500 52-Week Change 3 | N/A |
| 52 Week High 3 | 0.0019 |
| 52 Week Low 3 | 0.0004 |
| 50-Day Moving Average 3 | 0.0007 |
| 200-Day Moving Average 3 | 0.0008 |
Share Statistics
| Avg Vol (3 month) 3 | 17.42M |
| Avg Vol (10 day) 3 | 4.55M |
| Shares Outstanding 5 | 4.88B |
| Implied Shares Outstanding 6 | N/A |
| Float 8 | 3.83B |
| % Held by Insiders 1 | 22.57% |
| % Held by Institutions 1 | 0.00% |
| Shares Short 4 | N/A |
| Short Ratio 4 | N/A |
| Short % of Float 4 | N/A |
| Short % of Shares Outstanding 4 | N/A |
| Shares Short (prior month ) 4 | N/A |
Dividends & Splits
| Forward Annual Dividend Rate 4 | N/A |
| Forward Annual Dividend Yield 4 | N/A |
| Trailing Annual Dividend Rate 3 | 0.00 |
| Trailing Annual Dividend Yield 3 | 0.00% |
| 5 Year Average Dividend Yield 4 | N/A |
| Payout Ratio 4 | 0.00% |
| Dividend Date 3 | N/A |
| Ex-Dividend Date 4 | N/A |
| Last Split Factor 2 | N/A |
| Last Split Date 3 | N/A |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | Dec 31, 2023 |
| Most Recent Quarter (mrq) | Jun 30, 2024 |
Profitability
| Profit Margin | 0.00% |
| Operating Margin (ttm) | -2,019.68% |
Management Effectiveness
| Return on Assets (ttm) | -36.00% |
| Return on Equity (ttm) | -139.00% |
Income Statement
| Revenue (ttm) | 91.38k |
| Revenue Per Share (ttm) | 0.00 |
| Quarterly Revenue Growth (yoy) | -24.00% |
| Gross Profit (ttm) | N/A |
| EBITDA | -1.78M |
| Net Income Avi to Common (ttm) | -2M |
| Diluted EPS (ttm) | -0.0000 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 8.32k |
| Total Cash Per Share (mrq) | 0 |
| Total Debt (mrq) | 961.5k |
| Total Debt/Equity (mrq) | 52.38 |
| Current Ratio (mrq) | 0.40 |
| Book Value Per Share (mrq) | 0.00 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -866.03k |
| Levered Free Cash Flow (ttm) | -256.65k |
Advertisement
Advertisement
© 2024 Yahoo. All rights reserved.